激酶生物服务市场－全球产业规模、份额、趋势、机会和预测（按类型、应用、地区和竞争细分，2020-2030 年预测）

2024 年全球激酶生物服务市场价值为 10.8 亿美元，预计在预测期内将实现强劲增长，到 2030 年的复合年增长率为 10.02%。全球激酶生物服务市场已成为更广泛的生命科学和製药行业中关键且充满活力的领域。激酶是一类调节各种细胞过程的酶，在药物发现和开发中具有重要意义，因此激酶参与调节多种生物过程，包括细胞生长、增殖、分化和凋亡。激酶失调通常与癌症、发炎性疾病和神经退化性疾病等疾病有关。

因此，激酶的研究已成为了解疾病机制和确定潜在治疗标靶的核心。全球激酶生物学服务市场涵盖了为支持激酶相关研究而量身定制的广泛服务和产品。这些服务包括激酶检测开发、高通量筛选、激酶分析和激酶抑制剂筛选等。它们使製药和生物技术公司、学术机构和研究组织能够透过识别和表征可作为潜在候选药物的激酶抑制剂来加速药物发现。

关键市场驱动因素

癌症和慢性病发生率上升

主要市场挑战

激酶生物学服务成本高昂

主要市场趋势

标靶治疗和个人化医疗

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球激酶生物服务市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（基于 ELISA 的测试、酶促测试、基于比色法的测试、其他）
  • 按应用（诊断用途、研究用途）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美激酶生物服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲激酶生物服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太激酶生物服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美激酶生物服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲激酶生物服务市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Jena Bioscience GmbH
• Qiagen NV
• Merck & Co., Inc
• Promega Corporation
• Takara Bio Inc.
• Reaction Biology Corporation (RBC)
• Nanosyn

第 16 章：策略建议

第17章调查会社について・免责事项

Global Kinase Biology Services Market was valued at USD 1.08 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.02% through 2030. The Global Kinase Biology Services Market has emerged as a critical and dynamic sector within the broader life sciences and pharmaceutical industries. Kinases, a class of enzymes that regulate various cellular processes, have gained immense importance in drug discovery and development, making kin Kinases are involved in the regulation of diverse biological processes, including cell growth, proliferation, differentiation, and apoptosis. Dysregulation of kinases is often associated with diseases such as cancer, inflammatory disorders, and neurodegenerative conditions.

Consequently, the study of kinases has become central to understanding disease mechanisms and identifying potential therapeutic targets. The Global Kinase Biology Services Market encompasses a wide range of services and products tailored to support kinase-related research. These services include kinase assay development, high-throughput screening, kinase profiling, and kinase inhibitor screening, among others. They enable pharmaceutical and biotechnology companies, academic institutions, and research organizations to accelerate drug discovery by identifying and characterizing kinase inhibitors, which can be used as potential drug candidates.

Key Market Drivers

Rising Prevalence of Cancer and Chronic Diseases

Kinases are enzymes that regulate a wide range of cellular processes, including cell growth, division, and survival. In cancer and several chronic diseases, dysregulation of kinase activity is a common molecular hallmark. This makes kinases high-value therapeutic targets, especially in the development of targeted therapies and precision medicines. In 2022, global cancer incidence reached an estimated 20 million new cases, resulting in 9.7 million deaths. Additionally, approximately 53.5 million individuals were living within five years of a cancer diagnosis, reflecting the increasing burden on healthcare systems and long-term care infrastructure. As the global burden of diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune diseases continues to rise, there is a corresponding increase in demand for effective and targeted treatments. This creates a strong commercial incentive for pharmaceutical and biotechnology companies to focus their R&D efforts on kinase-related pathways, which in turn boosts demand for specialized kinase biology services.

Key Market Challenges

High Cost of Kinase Biology Services

The Global Kinase Biology Services Market has emerged as a critical player in the realm of drug discovery and disease understanding. Kinases, enzymes that regulate various cellular processes, hold immense potential in the development of targeted therapies. One primary reason for the elevated costs in kinase biology services is the complexity of the field itself. Kinase signaling pathways are intricate and multifaceted, requiring specialized knowledge, expertise, and cutting-edge technologies for their study. This complexity necessitates the involvement of skilled researchers and technicians who are well-versed in kinase biology, adding to the overall expenses. Another cost-driving factor is the need for sophisticated equipment and resources. Kinase assays, high-throughput screening, kinase profiling, and other related services rely heavily on state-of-the-art laboratory instrumentation. Maintaining and operating these tools, along with the cost of consumables and reagents, contribute significantly to the overall service fees. The high cost of kinase biology services can result in limited accessibility, particularly for smaller biotechnology companies, academic institutions, and emerging startups with constrained budgets. This accessibility gap can stifle innovation and prevent potentially groundbreaking research from reaching its full potential. It may also deter smaller entities from pursuing kinase-related projects, which could otherwise contribute significantly to the market's growth.

Key Market Trends

Targeted Therapies and Personalized Medicine

In the era of targeted therapies, the emphasis is on identifying and inhibiting specific molecular targets responsible for disease initiation and progression. Kinases frequently feature as these targets due to their central role in many diseases, making them attractive candidates for drug discovery efforts. The Global Kinase Biology Services Market is witnessing a surge in demand as pharmaceutical companies, research institutions, and biotechnology firms seek specialized services to identify and validate kinase inhibitors tailored to individual patients' genetic profiles. Personalized medicine hinges on the notion that every patient is unique, and treatments should reflect this individuality. As a result, kinase biology services have gained prominence in analyzing patients' genetic makeup to pinpoint the specific mutations or alterations in kinase activity driving their diseases. By tailoring therapies based on these genetic insights, clinicians can optimize treatment strategies, increasing efficacy and minimizing side effects. The application of personalized medicine extends beyond cancer, encompassing various chronic and rare diseases where kinase biology plays a pivotal role. This broadens the scope of the Kinase Biology Services Market, as researchers and pharmaceutical companies delve into the development of targeted therapies for conditions such as neurodegenerative disorders, autoimmune diseases, and cardiovascular ailments.

Key Market Players

• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Jena Bioscience GmbH
• Qiagen N.V.
• Merck & Co., Inc
• Promega Corporation
• Takara Bio Inc.
• Reaction Biology Corporation (RBC)
• Nanosyn

Report Scope:

In this report, the Global Kinase Biology Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kinase Biology Services Market, By Type:

• ELISA Based Tests
• Enzymatic Tests
• Colorimetric Assay Based Tests
• Others

Kinase Biology Services Market, By Application:

• Diagnosis Use
• Research Use

Kinase Biology Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kinase Biology Services Market.

Available Customizations:

Global Kinase Biology Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kinase Biology Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (ELISA Based Tests, Enzymatic Tests, Colorimetric Assay Based Tests, Others)
  • 5.2.2. By Application (Diagnosis Use, Research Use)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Kinase Biology Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Kinase Biology Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Kinase Biology Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Kinase Biology Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Kinase Biology Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Kinase Biology Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Kinase Biology Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Kinase Biology Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Kinase Biology Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Kinase Biology Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Kinase Biology Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Kinase Biology Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Kinase Biology Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Kinase Biology Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Kinase Biology Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Kinase Biology Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Kinase Biology Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Kinase Biology Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Kinase Biology Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Kinase Biology Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Kinase Biology Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Kinase Biology Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Kinase Biology Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Kinase Biology Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. F. Hoffmann-La Roche Ltd
• 15.3. Jena Bioscience GmbH
• 15.4. Qiagen N.V.
• 15.5. Merck & Co., Inc
• 15.6. Promega Corporation
• 15.7. Takara Bio Inc.
• 15.8. Reaction Biology Corporation (RBC)
• 15.9.Nanosyn

16. Strategic Recommendations

17. About Us & Disclaimer